Botox
Scope
Date
~
-
Bio & Pharma
Korean botox sales gain momentum in US, China
South Korea is ramping up exports of botulinum toxin to the US and China, the world’s two top consumers of the neurotoxin protein, with its pr...
Apr 29, 2024 (Gmt+09:00)
-
Bio & Pharma
Korean court rules Daewoong poached Medytox’s botox strain
A South Korean court on Friday ruled in favor of Medytox Inc. in a civil lawsuit against its crosstown rival Daewoong Pharmaceutical Co. over the so...
Feb 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Hugel accelerates European botox sales with Poland's approval
Hugel Inc., South Korea’s largest maker of botulinum toxin products used to treat overactive muscles and facial wrinkles, has won sales approv...
Jun 03, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong's Nabota approved for sale in Saudi Arabia, Ukraine
South Korea’s Daewoong Pharmaceutical Co. has obtained approval for the sale of its botulinum toxin product, Nabota, in Saudi Arabia and Ukrai...
May 19, 2022 (Gmt+09:00)
-
Bio & Pharma
Medytox-Hugel dispute over botox strain intensifies with ITC probe
A legal dispute over a botox strain between South Korean pharmaceutical company Medytox Inc. and its crosstown rival Hugel Inc. has intensified with...
May 03, 2022 (Gmt+09:00)
-
Bio & Pharma
Medytox files complaint with ITC against Hugel over botox strain
South Korean pharmaceutical company Medytox Inc. has filed a complaint with the International Trade Commission (ITC) against Hugel Inc., alleging th...
Apr 01, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
GS ups spending to take control of botox maker Hugel
South Korea’s energy-to-retail conglomerate GS Group has increased its spending to become the largest shareholder in Hugel Inc., the country's...
Feb 13, 2022 (Gmt+09:00)
-
Pharmaceuticals
Medytox’s US business outlook dim as contract with AbbVie ends
South Korea’s pharmaceutical company Medytox Inc. has ended a botulinum toxin-related technology transfer contract with AbbVie, clouding its b...
Sep 09, 2021 (Gmt+09:00)
-
Mergers & Acquisitions
Bain Capital sells management rights of Hugel to GS-led group for $1.5 bn
A consortium led by South Korea’s energy-to-construction conglomerate GS Group has acquired the country’s top botox maker Hugel Inc. fro...
Aug 25, 2021 (Gmt+09:00)
language -
M&As
Mubadala joins GS-led group to buy Korean botox maker
Abu Dhabi’s sovereign investor Mubadala Investment Co. joined a consortium led by South Korean GS Group to acquire the country’s top bot...
Aug 11, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
Bid for botox maker Hugel to kick off in late July, attracts PEFs
The bid to acquire a controlling stake in Hugel Inc., South Korea’s leading maker of botulinum toxin, more commonly known as botox, from US pr...
Jul 23, 2021 (Gmt+09:00)
language -
Mergers & Acquisitions
Samsung looks to acquire bio company, reviews botox maker Hugel
Samsung Group is looking to buy a biopharmaceutical company as the top South Korean business conglomerate is resuming merger and acquisition activit...
Jul 20, 2021 (Gmt+09:00)
-
Pharmaceuticals
GS Group joins race to acquire Korea’s botox maker Hugel
A consortium led by South Korea’s GS Group is in talks to acquire a controlling stake in Hugel Inc., the country’s top maker of botulinu...
Jun 28, 2021 (Gmt+09:00)
language -
Beauty & Cosmetics
Korean medical cosmetics firms make big rebound in Q1
South Korean medical cosmetics companies that underwent a tough year in 2020 are posting rejuvenated earning results thanks to s rise in demand in E...
May 24, 2021 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand